Teva Pharmaceutical Industries Limited NYQ · TEVA
Price alert —
Sign in to get a one-time email the moment TEVA crosses your price. Free accounts included.
Sign in / create a free accountTeva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally.
TEVA last traded at $32.03, down 0.6% on the day; that's in the middle part of its 52-week range ($27.93–$37.35). Right now it's dipped below its recent average — a spot where watchers often look for signs the dip is stabilizing.
The next scheduled earnings report (2026-07-29) is the biggest known catalyst on the calendar, and after the recent dip, watch whether the price stops making lower lows before assuming the worst is over.
A plain-English snapshot built from the data on this page — not investment advice. Always do your own research.
below KC1 upper, -0.92 ATR from EMA21 — shooting star
- · Aligned with weak uptrend
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
- · Shooting star — long upper wick rejection
Each bar shows how many points that factor added. The more points — and the more factors that agree — the higher the letter grade.
TEVA is a $37.3 billion company, priced at 24× last year's earnings.
Options idea
See more →Earnings
See more →- Last reported
- 2026-04-29
- EPS (act / est)
- 0.53 / 0.46
- Surprise
- +16.2%
- Next report
- 2026-07-29
About
Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic and other medicines, and biopharmaceutical products in the United States, Europe, Israel, and internationally. It offers generic medicines in various dosage forms, such as tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams; sterile products…